Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 22, 2015

View Archived Issues

Osaka University starts phase I/II trial of CNT-01 in patients with idiopathic TGCV

Tohoku University, Gunma University and Fuso disclose OPN production inhibitors

Glycemic improvements similar with omarigliptin and sitagliptin in patients with type 2 diabetes

Pediatric schistosomiasis candidate L-praziquantel safe in phase I study in healthy volunteers

New mutation in HNF1B identified in patient with maturity-onset diabetes of the young type 5

Rat forelimb allotransplantation model enables assessment of function

FDA grants fast track designation to Alcobra's metadoxine extended release

Transgenic pigs used to model gestational diabetes

Glide Technologies and Cilian to develop novel solid dose recombinant influenza vaccine

Palatin Technologies and Richter terminate license agreement for bremelanotide

Saniona reports data supporting the use of Tesomet in type 2 diabetes, plans proof-of-concept study

Artificially designed peptide inhibits HIV fusion with improved pharmacological properties

AcelRx sells portion of Zalviso royalty stream to PDL BioPharma

Phase III induction trials of tofacitinib in ulcerative colitis meet primary endpoints

Companies receive funding to advance Ebola programs

Harbour Antibodies signs new licenses to transgenic mouse platforms

Roche reports compounds for the treatment of hepatitis B

Gilead reports topline results from four phase III studies of sofosbuvir/velpatasvir for HCV

Aerie initiates phase III trial of Roclatan

Akari Therapeutics formed to develop treatments for diseases involving complement C5

Plexxikon discloses c-Kit inhibitors

Clinical effect of K-877 may be superior to fibrate drugs on the market

Taro launches Keveyis for primary hyperkalemic and hypokalemic periodic paralysis

Pharmaxis reports phase I results for PXS-4728A

LFB's IVIg Iqymune approved in U.K. and Denmark

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...